Albuterol Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Alerts
• Clinical Trials
• Forums

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
Condition:   Asthma Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg;   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Budesonide metered-dose inhaler 160 µg;   Combination Product: Albuterol sulfate metered-dose inhale r 180 μg;   Combination Product: Placebo metered-dose inhaler Sponsor:   Bond Avillion 2 Development LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials